openPR Logo

Press Releases from Cardiovascular Disorders Drug Development Market (1 total)

Cardiovascular Disorders Drug Development Market 2019| Takeda Pharmaceutical, Ot …

Albany, NY, 31st January : Recent research and the current scenario as well as future market potential of "Cardiovascular Disorders Drug Development Pipeline Review, 2017" globally. Cardiovascular disease (CVD) covers a range of difference diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia of which accelerate the development of atherosclerotic plaques building up within blood vessels. Get PDF for more Professional

Go To Page:   1 2 3 4 5 6 7 8 9 10